As of 2024-12-15, the Intrinsic Value of CryoLife Inc (CRY) is
2.03 USD. This CRY valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 17.88 USD, the upside of CryoLife Inc is
-88.60%.
The range of the Intrinsic Value is (1.48) - 22.64 USD
CRY Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(1.48) - 22.64 |
2.03 |
-88.6% |
| DCF (Growth 10y) |
3.71 - 52.26 |
10.81 |
-39.5% |
| DCF (EBITDA 5y) |
4.90 - 7.29 |
6.16 |
-65.5% |
| DCF (EBITDA 10y) |
10.20 - 15.99 |
13.04 |
-27.1% |
| Fair Value |
1.41 - 1.41 |
1.41 |
-92.12% |
| P/E |
(1.11) - (1.10) |
(1.12) |
-106.3% |
| EV/EBITDA |
(0.92) - 19.42 |
9.44 |
-47.2% |
| EPV |
3.49 - 8.02 |
5.75 |
-67.8% |
| DDM - Stable |
(0.35) - (2.37) |
(1.36) |
-107.6% |
| DDM - Multi |
(0.50) - (2.59) |
(0.83) |
-104.7% |
CRY Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
703.22 |
| Beta |
1.54 |
| Outstanding shares (mil) |
39.33 |
| Enterprise Value (mil) |
953.18 |
| Market risk premium |
4.24% |
| Cost of Equity |
8.00% |
| Cost of Debt |
6.77% |
| WACC |
7.35% |